The Michigan House on Thursday passed a package of bills that would repeal a 13-year-old law that provides pharmaceutical companies with immunity from lawsuits involving FDA-approved products, the Detroit News reports. The main bill was passed by a 61-48 vote and the other bills passed with similar or narrower margins, according to the News. Current law allows plaintiffs to collect legal damages only if they can prove that a company withheld or misrepresented information that would result in FDA revoking its approval of a drug. The legislation would repeal the law retroactive to 1996 (Heinlein, Detroit News, 3/26).

Reprinted with kind permission from kaisernetwork. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at kaisernetwork/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork, a free service of The Henry J. Kaiser Family Foundation.

© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.